As of 2024-12-11, the EV/EBITDA ratio of Alligator Bioscience AB (ATORX.ST) is -0.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ATORX.ST's latest enterprise value is 146.75 mil SEK. ATORX.ST's TTM EBITDA according to its financial statements is -227.63 mil SEK. Dividing these 2 quantities gives us the above ATORX.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.8x - 16.9x | 13.0x |
| Forward P/E multiples | 16.6x - 24.7x | 18.8x |
| Fair Price | (4.95) - (5.02) | (4.72) |
| Upside | -2131.6% - -2163.6% | -2040.3% |
| Date | EV/EBITDA |
| 2024-11-28 | -1.65 |
| 2024-11-27 | -1.62 |
| 2024-11-26 | -1.56 |
| 2024-11-25 | -1.61 |
| 2024-11-22 | -1.59 |
| 2024-11-21 | -1.68 |
| 2024-11-20 | -1.51 |
| 2024-11-19 | -1.76 |
| 2024-11-18 | -1.88 |
| 2024-11-15 | -2.04 |
| 2024-11-14 | -2.09 |
| 2024-11-13 | -2.13 |
| 2024-11-12 | -2.09 |
| 2024-11-11 | -2.14 |
| 2024-11-08 | -2.15 |
| 2024-11-07 | -2.24 |
| 2024-11-06 | -2.04 |
| 2024-11-05 | -2.23 |
| 2024-11-04 | -2.16 |
| 2024-11-01 | -2.28 |
| 2024-10-31 | -2.41 |
| 2024-10-30 | -2.54 |
| 2024-10-29 | -2.59 |
| 2024-10-28 | -2.27 |
| 2024-10-25 | -2.16 |
| 2024-10-24 | -2.67 |
| 2024-10-23 | -3.72 |
| 2024-10-22 | -3.80 |
| 2024-10-21 | -3.86 |
| 2024-10-18 | -4.04 |
| 2024-10-17 | -4.04 |
| 2024-10-16 | -3.96 |
| 2024-10-15 | -4.10 |
| 2024-10-14 | -4.10 |
| 2024-10-11 | -4.18 |
| 2024-10-10 | -4.22 |
| 2024-10-09 | -4.28 |
| 2024-10-08 | -4.23 |
| 2024-10-07 | -4.18 |
| 2024-10-04 | -4.20 |
| 2024-10-03 | -4.17 |
| 2024-10-02 | -4.17 |
| 2024-10-01 | -4.14 |
| 2024-09-30 | -4.19 |
| 2024-09-27 | -4.26 |
| 2024-09-26 | -4.26 |
| 2024-09-25 | -4.26 |
| 2024-09-24 | -4.26 |
| 2024-09-23 | -4.30 |
| 2024-09-20 | -4.24 |